A Study of DKN-01 in Combination With Tislelizumab ± Chemotherapy in Patients With Gastric or Gastroesophageal Cancer
Clinical trial NCT04363801 · TERMINATED
Trial details
- NCT number
- NCT04363801
- Sponsor
- Leap Therapeutics, Inc.
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-07-29
- Primary completion
- 2025-03-31
- Enrollment
- 247
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.